1Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Eng J Med, 1991,325:1468-1475.
2The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Eng J Med, 1997,336:525-533.
3Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee toUpdate the 2001 Guidelines for the Evaluation and Management of Heart Failure). American College of Cardiology Web Site. Available at:http ://www. acc. org/clinical/guidelines/failure//index.pdf.
4The task force on acute heart failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005 ) : The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 2005,26: 1115-1140.
5Follath F, Cleland JG, Just H, et al. Efficacy and safety of intravenouslevos imendan compared with dobutamine in severe low-output heart failure (the LIDO study) : a randomized double-blind trial. Lancet, 2002,360 : 196-202.
